Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future
- 14 March 2001
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 19 (17-19), 2395-2399
- https://doi.org/10.1016/s0264-410x(00)00461-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- DNA VACCINESAnnual Review of Immunology, 1997
- Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis BHepatology, 1997
- Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene ImmunizationScience, 1996
- DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boostVaccine, 1996
- DNA-Mediated Immunization in Mice Induces a Potent MHC Class I-Restricted Cytotoxic T Lymphocyte Response to the Hepatitis B Envelope ProteinHuman Gene Therapy, 1995
- Hepatitis B Virus ImmunopathogenesisAnnual Review of Immunology, 1995
- Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.JCI Insight, 1995
- Specific vaccine therapy in chronic hepatitis B infectionThe Lancet, 1994
- DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibodyHuman Molecular Genetics, 1993
- Immunology and the liverHepatology, 1991